Showing 21 - 30 of 74
Persistent link: https://www.econbiz.de/10001502192
Persistent link: https://www.econbiz.de/10001579527
Persistent link: https://www.econbiz.de/10001216536
Persistent link: https://www.econbiz.de/10001192242
Persistent link: https://www.econbiz.de/10001227199
Persistent link: https://www.econbiz.de/10001182496
As states pass regulations to curb opioid abuse, what are the consequences for legitimate pain management? Forty-nine states have adopted prescription drug monitoring programs (PDMP) to detect potentially inappropriate opioid prescribing and use. Several studies have estimated the impact of...
Persistent link: https://www.econbiz.de/10013014121
Prior work considers effects of prescribing restrictions on opioid use but not upstream implications for pharmaceutical marketing activities, despite the inordinate role many believe marketing played in the crisis. Our study proposes a stylized model of pharmaceutical payments and investigates...
Persistent link: https://www.econbiz.de/10012861727
We investigate the predictive power of survey-elicited time preferences using a representative sample of US residents. In regressions controlling for demographics and risk preferences, we show that the discount factor elicited from choice experiments using multiple price lists and real payments...
Persistent link: https://www.econbiz.de/10013050283
Grim national statistics about the U.S. opioid crisis are increasingly well known to the American public. Far less well known is that U.S. war veterans are at ground zero of the epidemic, facing an overdose rate twice that of civilians. Post-9/11 deployments to Afghanistan and Iraq have exposed...
Persistent link: https://www.econbiz.de/10012480208